Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes Module 2
In this concluding module, Michael A. Davies, MD,…
Oncology Data Advisor · i3 Health
April 30, 202520m 58s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this concluding module, Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, addresses the critical challenges of managing treatment-associated toxicities in the era of advanced melanoma therapies. Discover practical strategies for handling immune-related adverse events, implementing comprehensive supportive care, and optimizing patient education. This podcast is critical for oncology professionals seeking to balance therapeutic efficacy with quality of life for patients receiving cutting-edge immunotherapy and targeted treatments.
Click here to go back and listen to module 1 of this podcast series: https://bit.ly/4iYmYD2
Click here to claim your CME/NCPD credit: https://bit.ly/44yO9RB